Cargando…

The impact of physical frailty on the response to inactivated influenza vaccine in older adults

Physical frailty’s impact on hemagglutination inhibition antibody titers (HAI) and peripheral blood mononuclear cell (PBMC) transcriptional responses after influenza vaccination is unclear. Physical frailty was assessed using the 5-item Fried frailty phenotype in 168 community- and assisted-living a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moehling, Krissy K., Zhai, Bo, Schwarzmann, William E., Chandran, Uma R., Ortiz, Marianna, Nowalk, Mary Patricia, Nace, David, Lin, Chyongchiou J., Susick, Michael, Levine, Min Z., Alcorn, John F., Zimmerman, Richard K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803506/ https://www.ncbi.nlm.nih.gov/pubmed/33347425 http://dx.doi.org/10.18632/aging.202207

Ejemplares similares

LB12. A Randomized Controlled Trial of Antibody Response to 2018–2019 Cell-based vs. Egg-based Quadrivalent Inactivated Influenza Vaccine in Children
por: Moehling, Krissy, et al.
Publicado: (2019)

99. Immune Responses to Influenza Vaccines in Children and Young Adults
por: Williams, Katherine V, et al.
Publicado: (2021)

Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination
por: Levine, Min Z., et al.
Publicado: (2016)

Inflammatory Mediator Expression Associated With Antibody Response Induced by Live Attenuated vs Inactivated Influenza Virus Vaccine in Children
por: Martin, Judith M, et al.
Publicado: (2018)

Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains
por: Nuñez, Ivette A., et al.
Publicado: (2017)

Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults
por: Spencer, Sarah, et al.
Publicado: (2021)

1125 Viral Infections In Outpatients With Medically Attended Acute Respiratory Illness During the 2012-13 Influenza Season
por: Zimmerman, Richard K., et al.
Publicado: (2014)

Influenza and other respiratory virus infections in outpatients with medically attended acute respiratory infection during the 2011-12 influenza season
por: Zimmerman, Richard K, et al.
Publicado: (2014)

Differential Gene Expression Elicited by Children in Response to the 2015–2016 Live Attenuated vs. Inactivated Influenza Vaccine
por: Zimmerman, Richard, et al.
Publicado: (2017)

Effect of mild COVID-19 on health-related quality of life
por: Nowalk, Mary Patricia, et al.
Publicado: (2023)

Using the 4 pillars™ practice transformation program to increase adult influenza vaccination and reduce missed opportunities in a randomized cluster trial
por: Lin, Chyongchiou J., et al.
Publicado: (2016)

Viral infections in outpatients with medically attended acute respiratory illness during the 2012–2013 influenza season
por: Zimmerman, Richard K, et al.
Publicado: (2015)

Detection of Influenza Virus Infection Using Two PCR Methods
por: Zimmerman, Richard K., et al.
Publicado: (2014)

Factors associated with in-office influenza vaccination by U.S. pediatric providers
por: Lin, Chyongchiou Jeng, et al.
Publicado: (2013)

Cost-Effectiveness of Newly Recommended Pneumococcal Vaccination Strategies in Older Underserved Minority Adults in the USA
por: Smith, Kenneth J., et al.
Publicado: (2022)

Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis
por: Smith, Kenneth J., et al.
Publicado: (2021)

1055 Antibody Response to Intradermal and High Dose Influenza Vaccine in 2012-13 Among Adults Who Did and Did Not Respond to Standard Dose Vaccine in 2011-12
por: Sundaram, Maria, et al.
Publicado: (2014)

Cost-effectiveness of increasing vaccination in high-risk adults aged 18–64 Years: a model-based decision analysis
por: Wateska, Angela R., et al.
Publicado: (2018)

Physical health and mental health functional status during and following hospitalization for an acute respiratory illness
por: Nowalk, Mary Patricia, et al.
Publicado: (2019)

Potential Cost-Effectiveness of a Universal Influenza Vaccine in Older Adults
por: France, Glenson, et al.
Publicado: (2018)

Blood Inflammatory Biomarkers Differentiate Inpatient and Outpatient Coronavirus Disease 2019 From Influenza
por: Luciani, Lauren L, et al.
Publicado: (2023)

Comparison of local influenza vaccine effectiveness using two methods
por: Balasubramani, G.K., et al.
Publicado: (2021)

The hidden societal cost of antibiotic resistance per antibiotic prescribed in the United States: an exploratory analysis
por: Michaelidis, Constantinos I., et al.
Publicado: (2016)

Standing orders for influenza and pneumococcal polysaccharide vaccination: Correlates identified in a national survey of U.S. Primary care physicians
por: Albert, Steven M, et al.
Publicado: (2012)

Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011–2012 to 2016–2017
por: Gaglani, Manjusha, et al.
Publicado: (2020)

Does influenza vaccination status change physician ordering patterns for respiratory viral panels? Inspection for selection bias
por: Balasubramani, G.K., et al.
Publicado: (2018)

Determination of Eligibility for Influenza Research: A Clinical Informatics Approach
por: Silveira, Fernanda P, et al.
Publicado: (2019)

650 Relative Vaccine Effectiveness of Live-Attenuated Versus Inactivated Influenza Vaccines in Children and Adolescents Aged 2–18 Years in Two Seasons – US Flu VE Network
por: Clippard, Jessie, et al.
Publicado: (2014)

Using capture‐recapture methods to estimate influenza hospitalization incidence rates
por: Balasubramani, Goundappa K., et al.
Publicado: (2021)

Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018–2019 and 2019–2020 calculated using a retrospective test-negative design
por: Zimmerman, Richard K., et al.
Publicado: (2023)

Vaccine effectiveness against COVID‐19 among symptomatic persons aged ≥12 years with reported contact with COVID‐19 cases, February–September 2021
por: Chung, Jessie R., et al.
Publicado: (2022)

2746. Effectiveness of Influenza Vaccine for Prevention of Influenza-associated Hospitalizations Among Immunocompromised Adults—2017–2018
por: Silveira, Fernanda P, et al.
Publicado: (2019)

1161. Effectiveness of the Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Infections in Outpatient Immunocompromised Adults, 2017-2018
por: Kramer, Kailey Hughes, et al.
Publicado: (2023)

1059 Expanded immunogenicity of high-dose inactivated influenza vaccine compared to standard-dose inactivated influenza vaccine in older adults
por: Diazgranados, Carlos, et al.
Publicado: (2014)

Predictors of colorectal cancer screening in diverse primary care practices
por: Zimmerman, Richard K, et al.
Publicado: (2006)

Estimating the burden of adult hospitalized RSV infection using local and state data - methodology
por: Balasubramani, G. K., et al.
Publicado: (2022)

Pre-frailty, frailty and associated factors in older caregivers of older adults
por: Máximo, Roberta de Oliveira, et al.
Publicado: (2020)

Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011‐2016
por: Balasubramani, Goundappa K., et al.
Publicado: (2020)

Frailty in older women
por: Fonseca, Anelise, et al.
Publicado: (2023)

Influenza infection is not associated with phenotypical frailty in older patients, a prospective cohort study
por: Takahashi, Paul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qfaovg9olel5gsdmu48selqtti